ST results further validated high E2F5 expression in NETs-enriched regions, suggesting that NETs may act as an “amplifier” of E2F5-mediated tumor-promoting signals, promoting LSCC invasion and metastasis by locally releasing pro-inflammatory factors and establishing an immunosuppressive microenvironment. The gene discussed is E2F5; the disease is neoplasm.